{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:58:11Z","timestamp":1794607091440,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022706","name":"Cole Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-186233"],"award-info":[{"award-number":["PJT-186233"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["834469"],"award-info":[{"award-number":["834469"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Societe de Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.isci.2025.111957","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T19:03:36Z","timestamp":1738695816000},"page":"111957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Jean Pierre","family":"Bikorimana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roudy","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamilah","family":"Abusarah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle Arona","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ali","family":"Erregragui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Pereira","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Lahrichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehme","family":"El-Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moutih","family":"Rafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.111957_bib1","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2025.111957_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153723","article-title":"Cancer immunotherapy: Challenges and limitations","volume":"229","author":"Taefehshokr","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.isci.2025.111957_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.isci.2025.111957_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s001090000108","article-title":"Cross-presentation: inducing CD8 T\u00a0cell immunity and tolerance","volume":"78","author":"Kurts","year":"2000","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.isci.2025.111957_bib5","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1126\/science.1080106","article-title":"Activation of lysosomal function during dendritic cell maturation","volume":"299","author":"Trombetta","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.111957_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.111957_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in\u00a0vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.111957_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.111957_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ncb1552","article-title":"Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes","volume":"9","author":"Jancic","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2025.111957_bib10","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1182\/blood-2008-01-134791","article-title":"NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells","volume":"112","author":"Mantegazza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.isci.2025.111957_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/emboj.2011.440","article-title":"Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner","volume":"31","author":"Rybicka","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2025.111957_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2006.05.035","article-title":"NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells","volume":"126","author":"Savina","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111957_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.immuni.2009.01.013","article-title":"The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells","volume":"30","author":"Savina","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2025.111957_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep22064","article-title":"Lipid peroxidation causes endosomal antigen release for cross-presentation","volume":"6","author":"Dingjan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.111957_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-physiol-021113-170305","article-title":"Exocytosis and endocytosis: modes, functions, and coupling mechanisms","volume":"76","author":"Wu","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.isci.2025.111957_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(91)90202-A","article-title":"Naming a targeting signal","volume":"64","author":"Varshavsky","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111957_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.molcel.2020.01.010","article-title":"Harnessing the Power of Proteolysis for Targeted Protein Inactivation","volume":"77","author":"Verma","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2025.111957_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/d41573-021-00052-4","article-title":"Targeted protein degraders crowd into the clinic","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.111957_bib19","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1002\/anie.202004310","article-title":"Prey for the Proteasome: Targeted Protein Degradation\u2014A Medicinal Chemist's Perspective","volume":"59","author":"Luh","year":"2020","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.isci.2025.111957_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature06926","article-title":"Proteasome subunit Rpn13 is a novel ubiquitin receptor","volume":"453","author":"Husnjak","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111957_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad9421","article-title":"Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome","volume":"351","author":"Shi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.111957_bib22","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1016\/S0021-9258(17)37244-7","article-title":"A 26\u00a0S protease subunit that binds ubiquitin conjugates","volume":"269","author":"Deveraux","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2025.111957_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbrc.2012.01.152","article-title":"The N-terminal domain of Rpn4 serves as a portable ubiquitin-independent degron and is recognized by specific 19S RP subunits","volume":"419","author":"Ha","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2025.111957_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm1039","article-title":"Dendritic cell immunotherapy: mapping the way","volume":"10","author":"Figdor","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.111957_bib25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nri1498","article-title":"Mechanisms and functional significance of tumour-induced dendritic-cell defects","volume":"4","author":"Gabrilovich","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.111957_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1711.2005.01371.x","article-title":"Dendritic cell dysfunction in cancer: a mechanism for immunosuppression","volume":"83","author":"Pinzon-Charry","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.isci.2025.111957_bib27","article-title":"Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice","volume":"2","author":"Abusarah","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.111957_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105537","article-title":"The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells","volume":"25","author":"Bikorimana","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.isci.2025.111957_bib29","article-title":"Thymoproteasome-expressing mesenchymal stromal cells confer protective anti-tumor immunity via cross-priming of endogenous dendritic cells","volume":"11","author":"Bikorimana","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.111957_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13287-021-02693-z","article-title":"UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells","volume":"13","author":"Salame","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.isci.2025.111957_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040596","article-title":"Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes","volume":"11","author":"Bikorimana","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2025.111957_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111816","article-title":"LSD1 inhibition enhances the immunogenicity of mesenchymal stromal cells by eliciting a dsRNA stress response","volume":"11","author":"Mardani","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2025.111957_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","article-title":"Targeting Strategies for Tissue-Specific Drug Delivery","volume":"181","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111957_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12040410","article-title":"Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research","volume":"12","author":"Skakic","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.111957_bib35","doi-asserted-by":"crossref","first-page":"12417","DOI":"10.1039\/D1CC04846E","article-title":"Nanoscale covalent organic frameworks: from controlled synthesis to cancer therapy","volume":"57","author":"He","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.isci.2025.111957_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.isci.2025.111957_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103981","article-title":"Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy","volume":"29","author":"Dai","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2025.111957_bib38","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/IJN.S357462","article-title":"Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in\u00a0vivo","volume":"17","author":"Lu","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.isci.2025.111957_bib39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1039\/C8BM01272E","article-title":"In\u00a0vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles","volume":"7","author":"Gulla","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.isci.2025.111957_bib40","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3762\/bjnano.14.75","article-title":"Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics","volume":"14","author":"Kumari","year":"2023","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.isci.2025.111957_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi2046","article-title":"Antibody nanoparticle conjugate\u2013based targeted immunotherapy for non\u2013small cell lung cancer","volume":"10","author":"Saha","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2025.111957_bib42","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In\u00a0vivo human T\u00a0cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111957_bib43","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/acscentsci.3c00625","article-title":"Enhanced Vaccine Immunogenicity Enabled by Targeted Cytosolic Delivery of Tumor Antigens into Dendritic Cells","volume":"9","author":"Truex","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.isci.2025.111957_bib44","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1007\/s00262-022-03209-1","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapy","volume":"71","author":"Tang","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2025.111957_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105324","article-title":"Efficient antigen delivery by dendritic cell-targeting peptide via nucleolin confers superior vaccine effects in mice","volume":"25","author":"Matsuda","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.isci.2025.111957_bib46","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/s41467-019-09974-5","article-title":"A modular degron library for synthetic circuits in mammalian cells","volume":"10","author":"Chassin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111957_bib47","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/embor.2011.203","article-title":"A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen","volume":"12","author":"Merzougui","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.isci.2025.111957_bib48","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41467-018-04686-8","article-title":"Mitochondrial reactive oxygen species regulate the induction of CD8+ T\u00a0cells by plasmacytoid dendritic cells","volume":"9","author":"Oberkampf","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111957_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/mcp.M110.006924","article-title":"Oxidative stress-mediated regulation of proteasome complexes","volume":"10","author":"Aiken","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.isci.2025.111957_bib50","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/S0021-9258(18)69126-4","article-title":"The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration","volume":"263","author":"Wilson","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2025.111957_bib51","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1038\/s41467-021-26834-3","article-title":"Mesenchymal stromal cell apoptosis is required for their therapeutic function","volume":"12","author":"Pang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111957_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in\u00a0vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.111957_bib53","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-08-0160","article-title":"Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy","volume":"68","author":"Eliopoulos","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.111957_bib54","first-page":"2384","article-title":"Vesicular stomatitis virus G pseudotyped retrovector mediates effective in\u00a0vivo suicide gene delivery in experimental brain cancer","volume":"59","author":"Galipeau","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.111957_bib55","article-title":"Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity","volume":"3","author":"Bikorimana","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.111957_bib56","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.111957_bib57","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:22:53Z","timestamp":1786411373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2589004225002172"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.111957","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.111957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111957"}}